Northwest Biotherapeutics (NWBO) Preferred Dividend Payments (2016 - 2026)

Northwest Biotherapeutics' Preferred Dividend Payments history runs 7 years deep, the most recent figure standing at $331000.0 for Q1 2026.

• On a quarterly basis, Preferred Dividend Payments rose 24.91% year-over-year to $331000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 24.3% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 7.0% from the prior year.
• Preferred Dividend Payments advanced to $331000.0 in Q1 2026 per NWBO's latest filing, from $137000.0 in the prior quarter.
• Across five years, Preferred Dividend Payments topped out at $568000.0 in Q1 2024 and bottomed at $132000.0 in Q3 2024.
• The 4-year median for Preferred Dividend Payments is $367000.0 (2023), against an average of $373846.2.
• Across the five-year window, Preferred Dividend Payments plunged 74.57% in 2024 and surged 167.42% in 2025, its largest moves.
• Year by year, Preferred Dividend Payments stood at $367000.0 in 2023, then decreased by 25.61% to $273000.0 in 2024, then slumped by 49.82% to $137000.0 in 2025, then soared by 141.61% to $331000.0 in 2026.
• Per Business Quant, the three latest NWBO Preferred Dividend Payments figures stand at $331000.0 (Q1 2026), $137000.0 (Q4 2025), and $353000.0 (Q3 2025).